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 Cancer is the second leading cause of death in the United States behind 
heart disease. The American Cancer Society (ACS) estimates that more than 1.6 
million people will be diagnosed with cancer in 2012, with over 577,000 deaths 
(Siegel et al., 2012). Specific phenotypes are acquired by normal cells as they 
develop into a tumor: sustained proliferative signaling, evasion of growth 
suppressive signals, resistance to cell death signals, induction of angiogenesis, 
replicative immortality, and invasion into the surrounding extracellular matrix 
(ECM) leading to metastasis (Hanahan & Weinberg, 2000, 2011). Invasion of 
cancer cells from the primary site is the key step in the progression of a tumor 
from a benign to a malignant state. Furthermore, the main cause of mortality from 
cancer is metastatsis: the colonization of tumor cells at sites distant from the 
primary tumor (Sporn, 1996; Pantel & Brakenhoff, 2004).  
Metastasis is a multi-step process during which cells must bypass several 
obstacles (Fidler, 2003). This begins with local proteolysis of the surrounding 
basement membrane (BM), a densely packed meshwork of laminin, type IV 
collagen, proteoglycans and glycoproteins (Rowe & Weiss, 2008). The cell may 
then invade into and through the surrounding stroma, a more loosely packed 
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connective tissue area surrounding the tumor that is comprised primarily of type I 
collagen fibers, along with fibroblasts and immune cells (Kufe et al., 2006). If an 
invading cell comes in contact with a blood vessel, it may intravasate into the 
vessel, which can be facilitated by leaky vessels recruited via angiogenesis by 
the primary tumor (Folkman, 1971). From there, the cancer cell must survive in 
the bloodstream and attach to the blood vessel wall at a distant site in order to 
extravasate out of the vessel, invade through the new local tissue, and begin to 
proliferate, forming a metastasis. Micrometastatic lesions consisting of single or 
small groups of cells can lead to macroscopic tumors in a process termed 
colonization, which can be preceded by a period of dormancy that can last 
decades in some cancer types (Aguirre-Ghiso, 2007). Each of these steps can 
be rate-limiting to the process of metastasis (Poste & Fidler, 1980). Therefore, 
understanding mechanisms of cancer cell invasion is critical to develop therapies 
to decrease cancer mortality.  
 
Cancer Cell Invasion 
 Tumor cells can adopt varying modes of migration and invasion to 
traverse the complex structure of BM and stroma surrounding the primary tumor 
(Friedl & Alexander, 2011). The first step of invasion is breaching the surrounding 
BM (Barsky et al., 1983; Spaderna et al., 2006), which requires membrane type 
matrix metalloproteinase (MT-MMP) activity (Hotary et al., 2006; Rowe & Weiss, 
2008). This invasion type can also be used while invading the BM surrounding 
blood vessels (Laug et al., 1983; Blood & Zetter, 1990).  
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Cancer cells can adopt varying modes of migration to navigate the more 
fibrillar tissue stromal areas surrounding the tumor (Friedl & Alexander, 2011). 
Single cells can migrate in amoeboid or mesenchymal fashion, dependent on the 
organization and structure of the stromal ECM. Amoeboid migration requires 
Rho-associated protein kinase (ROCK) and activity of the molecular motor 
myosin to contract the cell body and provide the force to move the cell through 
pores in the fibrillar matrix in a protease-independent fashion (Wolf et al., 2003; 
Wyckoff et al., 2006). This mode of migration is likely to be used in areas of 
sparse, lightly cross-linked, or otherwise disrupted or defective ECM (Sabeh et 
al., 2009; Madsen & Sahai, 2010). Mesenchymal migration is protease-
dependent and requires adhesion to the ECM through focal adhesions (FAs) 
(Cukierman et al., 2001; Li et al., 2003; Wolf et al., 2007). The protease activity 
serves to both clear space for the cell to move through the connective tissue and 
create tracks of reorganized ECM fibers (Wolf et al., 2007) along which 
advancing cells can migrate more efficiently (Provenzano et al., 2008b; Doyle et 
al., 2009). Cancer cells can also invade collectively from the primary tumor 
(Giampieri et al., 2009). This process requires “leader” cells migrating in a 
mesenchymal fashion to create the path as well as intact cell to cell adhesion 
(Wolf et al., 2007; Scott et al., 2010). These invasive modes of migration can 
occur in combination to allow cancer cells to invade from the primary tumor. 







Overview and History 
 A cellular structure thought to be important in degradation of the BM ECM 
is an invadopodium (Weaver, 2006; Parekh & Weaver, 2009). Invadopodia are 
small, sub-cellular structures that require actin polymerization machinery to 
protrude from the ventral surface of the cell and degrade matrix.  
 Evidence for invasive ventral sub-cellular protrusions was first observed in 
Rous sarcoma virus (RSV)-transformed fibroblasts, as proteins previously 
localized at FAs (vinculin and α-actinin) were relocated into “rosette” structures 
upon RSV infection (David-Pfeuty & Singer, 1980). These structures were called 
cellular feet or “podosomes” due to electron microscopy (EM) images showing 
ventral protrusions on fibronectin (FN)-coated plastic (Tarone et al., 1985). These 
protrusions presented as punctate and clustered rosette podosome structures 
localizing actin and phospho-tyrosine by immunofluorescence. Meanwhile, Wen-
Tien Chen, with others, demonstrated a punctate loss of underlying fluorescently-
labeled FN in RSV-transformed fibroblasts suggesting that these podosomes 
could degrade ECM (Chen et al., 1984; Chen et al., 1985). The loss of FN 
localized with vinculin, α-actinin, and viral-Src, a form of the Src tyrosine kinase 
lacking its C-terminal auto-inhibitory domain responsible for the transforming 
ability of RSV (Martin, 1970). FN clearing was dependent on MMPs (Chen et al., 




The terms podosome and invadopodium have often been used 
interchangeably, especially in cells transformed with viral-Src or Src Y527F, 
which abrogates regulatory phosphorylation resulting in an active Src kinase 
(Cooper et al., 1986; Hunter, 1987). Currently, the term podosome is generally 
used to describe these actin-based invasive structures in normal cells, while 
invadopodia is used in cancer cells. In various Src-transformed cells, 
podosomes, invadopodia, and a new term, “invadosome” have all been used to 
describe these structures, with invadopodia and podosomes as classes of 
invadosomes (Linder et al., 2011). For the sake of this dissertation, invadopodia 
will refer to those structures in cancer cells, while invadosomes and podosomes 
will refer to the structures in Src-transformed and normal cells, respectively 
(Figure 1). 
Both invadopodia and podosomes are important for invasive cellular 
functions in various cell types. Podosomes contribute to formation of the sealing 
zone in osteoclasts and are important for bone resorption (Kanehisa et al., 1990; 
Miyauchi et al., 1990). Podosomes also form in other normal cells including 
macrophages, dendritic cells, endothelial cells, and vascular smooth muscle cells 
(VSMCs) (Gaidano et al., 1990; Burns et al., 2001; Hai et al., 2002; Moreau et 
al., 2003). Invadopodia form and degrade matrix in multiple types of human 
cancer cells (Chen et al., 1994; Monsky et al., 1994; Seals et al., 2005; Clark et 
al., 2007a) and are important for cellular invasion (Coopman et al., 1998; 
Schoumacher et al., 2010). Therefore, these structures play important roles in 
traversing ECM barriers in normal and pathologic cellular contexts. 
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Figure 1. Cellular Invasive Structures. A. Cartoon and IF of podosomes in primary 
human macrophages localizing F-actin with holes in fluorescent gelatin (matrix, 
black holes). B. Cartoon and IF of podosome/invadosome rosettes in Src-
transformed fibroblasts localized with degraded fluorescent FN. Images on right 
show typical adhesion structures surrounding F-actin-containing podosomes in 
murine macrophages (vinculin, A) or Src-transformed fibroblasts (paxillin, B). C. 
Cartoon and IF of F-actin containing invadopodia in MDA-MB-231 breast cancer cell 
line localized with degraded fluorescent gelatin. Adhesion localization data is 
sparse, but paxillin, integrins, and possibly vinculin may localize at or around 
invadopodia (see text). Images adapted from Linder et al., 2011: All cartoons, center 
of A and C, Cougoule et al., 2009: Right of A, (Webb et al., 2007): Center of B, Pan 
et al., 2011: Right of B. 
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Src-transformed cells have been a popular model for studying invasive 
cellular structures due to the robust formation of invadopodia-like puncta and 
more extensive rosette structures (Tarone et al., 1985; Badowski et al., 2008; 
Winograd-Katz et al., 2011). Expression of constitutively active Src generally 
leads to a loss of classic FAs replaced by invadosomes (David-Pfeuty & Singer, 
1980; Chen, 1989; Fincham et al., 1995; Winograd-Katz et al., 2011). Therefore, 
invadosomes represent the primary adhesive structure in Src-transformed cells, 
similar to podosomes in many normal cells such as macrophages. Meanwhile, 
cancer cells that produce invadopodia continue to form FAs, which could lead to 
a more complex and even competitive relationship between the two actin-based 
structures (Chan et al., 2009; Liu et al., 2009b).  
While invadosomes in Src-transformed cells share many similar features 
to invadopodia in cancer cells, there are some critical differences.  First, the 
presence of constitutively active Src inherently bypasses and/or alters some 
upstream signals that would otherwise come from growth factors and/or 
adhesions.  Thus, Src-transformed cells may not be the best model for studying 
how upstream signals lead to an invasive phenotype. Second, invadosome 
rosettes have a somewhat different structure from podosomes, invadopodia, and 
higher order organizations of podosomes, such as osteoclast sealing rings.  
Finally, for unknown reasons, it is extremely rare for cancer cells to express 
constitutively active Src kinase mutant molecules (Yeatman, 2004).  Therefore, 
there may be some key differences in how cancer cell invadopodia are activated 
and function, as compared to otherwise normal cells that are transformed with 
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constitutively active Src. 
 
Structure of Invadopodia and Podosomes 
 Both invadopodia and podosomes have been well characterized by 
indirect immunofluorescence (IF) and electron microscopy (EM). Both appear as 
punctate structures by IF at which actin, actin regulatory proteins such as Arp2/3, 
cortactin, Tks5, and N-WASp, proteases such as MT1-MMP, active Src, and 
tyrosine phosphorylated proteins have been localized (Weaver, 2006; Murphy & 
Courtneidge, 2011). The punctate structures are generally composed of the 
same components in invadopodia and podosomes, although differences have 
been noted in scaffolding proteins upstream of N-WASp and membrane 
dynamics (Artym et al., 2011; Oser et al., 2011). Invadosomes can further 
assemble into a secondary rosette structure as observed in Src-transformed 
cells. Podosomes also assemble into higher order structures, such as the sealing 
zone in osteoclasts. 
By EM, the invadosomes of Src-transformed fibroblasts form protrusions 
or large swaths of membrane in contact with the underlying glass coverslip or  
matrix protein (Tarone et al., 1985; Chen, 1989). Podosomes in normal cells are 
characterized as dome-shaped structures above the plasma membrane 
(Gawden-Bone et al., 2010), and exhibit a dense actin core with radial actin 
fibers extending outward that may anchor the podosome to the membrane 
(Luxenburg et al., 2007). On surfaces with ample space and a satisfactory ECM 
substrate in the ventral direction, podosomes in VSMCs, dendritic cells and 
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macrophages are protrusive and degrade into the underlying matrix (Gawden-
Bone et al., 2010; Quintavalle et al., 2011; Van Goethem et al., 2011). 
Invadopodia begin as multiple small, finger-like protrusions on the ventral surface 
of the cell (Bowden et al., 1999) that can mature into protrusions with branched 
actin filaments through most of the protrusion with bundled filaments at the tip 
(Schoumacher et al., 2010). These data suggest that, in a proper environment, 
invadopodia and podosomes similarly form protrusions, degrade and invade into 
the ECM. 
Podosomes are further characterized by a ring of adhesion proteins that 
surrounds the individual actin puncta or the rosette structure. In normal cells such 
as macrophages, podosomes are often the primary adhesive structure and are 
used for motility and invasion (Marchisio et al., 1984; Marchisio et al., 1987). 
Podosome formation induced in Src-transformed cells or VSMCs results in a 
local disassembly of FA (Chen et al., 1984; Kaverina et al., 2003; Burgstaller & 
Gimona, 2004). Invadopodia studies also demonstrated localization of adhesion-
related proteins including αVβ3 integrin and paxillin at the invadopodia puncta of 
normal fibroblasts and cancer cells (Bowden et al., 1999; Deryugina et al., 2001). 
Paxillin and its family member Hic-5 also localize in a ring surrounding the 
invadopodia core, as in podosomes (Desai et al., 2008; Pignatelli et al., 2012). 
The localization of adhesion proteins around and adhesion ability of invadopodia 
in cancer cells has been controversial, however, and has been suggested as a 
defining difference between invadopodia and podosomes (Linder et al., 2011; 
Murphy & Courtneidge, 2011).  
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A key feature of these structures is the localization with degraded holes in 
an underlying ECM. MT1-MMP is regarded as the primary invadopodial protease 
(Nakahara et al., 1997; Sabeh et al., 2004), and knockdown of MT1-MMP protein 
levels greatly reduces invadopodia function (Artym et al., 2006). Interestingly, 
invadopodia number is also decreased, to a lesser extent, by MMP inhibition, 
suggesting a positive feedback to invadopodia formation from degradation of the 
ECM (Artym et al., 2006; Clark et al., 2007a). Soluble proteases such as MMP-2 
and MMP-9 can be secreted from or activated by MT1-MMP at invadopodia 
(Deryugina et al., 2001; Artym et al., 2006). The serine protease seprase also 
localizes to invadopodia and is important for matrix degradation (Monsky et al., 
1994). Finally, a disintegrin and metalloprotease 12 (ADAM12) localizes to Src-
induced podosomes by binding to Tks5 (Abram et al., 2003). Therefore, a 
number of proteases facilitate ECM degradation by these structures, but MT1-
MMP is considered indispensable. 
 
Invadopodia and Podosomes in vivo 
 Due to their small size, invadopodia and podosomes have primarily been 
studied in vitro, as ventral protrusions into a thin ECM layer on glass coverslips. 
While cells can encounter these geometries in vivo, it has been unclear if 
podosome and invadopodia structures would assemble or behave similarly in 
vivo. Recently, direct evidence of podosome and invadopodia formation in vivo 
has come to light. In invading cells, traditional invadopodia and lamellipodia may 
merge to create invasive protrusions at the cell front. Breast cancer cells form 
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such invasive protrusions in 3D Matrigel culture that degrade ECM at the cell 
front which localize invadopodia markers such as cortactin and Tks5 (Magalhaes 
et al., 2011). Fibroblast or breast cancer cell invasion through 3D collagen gels 
can occur through similar protrusive structures that demonstrate collagenolytic 
activity at the base of the protrusion rather than the front, although no 
invadopodia markers were used in this study (Wolf et al., 2007). Invadopodia and 
podosomes have also recently been described in vivo. Immunoelectron 
microscopy of murine aortas shows localization of cortactin and Tks5 in 
podosome rosette structures in VSMCs (Quintavalle et al., 2011). In a breast 
cancer mouse model, tumor cells at the invasive front of the primary tumor 
exhibit leading edge protrusion with degradative ability in cryosections 
immunostained for cortactin, actin, N-WASp, and degraded collagen, with N-
WASp knockdown greatly reducing collagenolytic activity (Gligorijevic et al., 
2012). This is the first demonstration of invadopodia-like structures with 
degradative ability and canonical invadopodia markers in vivo. 
 
Stages of Invadopodia and Podosomes 
 Invadopodia have been shown to assemble in a step-wise fashion. 
Cortactin and actin aggregates form first, followed quickly by MT1-MMP 
recruitment to the invadopodia within minutes (Artym et al., 2006). Noticeable 
degradation of a thin layer of fluorescent ECM (~50 nm) can occur in the few 
minutes following MT1-MMP recruitment (Artym et al., 2006; Artym et al., 2009), 
while thicker layers (~1 µm) do not show holes in the matrix for 30 minutes to an 
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hour following cortactin appearance (Oser et al., 2009). This study also 
demonstrated immediate recruitment of MT1-MMP to cortactin punctate 
structures formed upon epidermal growth factor (EGF) stimulation (Oser et al., 
2009). However, cells treated with a pan-MMP inhibitor or with small interfering 
RNA (siRNA) targeting MT1-MMP exhibit a nearly complete loss of ECM 
degradation but only a 2- to 4-fold decrease in invadopodia number (Artym et al., 
2006; Clark et al., 2007a; Steffen et al., 2008). These data suggest that actin 
polymerization precedes MT1-MMP recruitment and local matrix degradation, 
while also implying a positive feedback loop between matrix degradation and 
invadopodia formation. 
 
Soluble Extracellular Signals Induce Invadopodia and Podosomes 
There are many extracellular cues that regulate invadopodium and 
podosome formation and function, including growth factor receptors and cell-
ECM interactions. Macrophages form podosomes in response to colony 
stimulating factor 1 (CSF-1), with phosphoinositide-3-kinase (PI3K) activity 
required downstream (Wheeler et al., 2006). Transforming growth factor beta 
(TGF-β) induces podosome formation in and invasion by endothelial cells 
through Src, PI3K, RhoA, and Cdc42 signaling (Varon et al., 2006; Rottiers et al., 
2009). Podosomes also form in endothelial cells in response to vascular 
endothelial growth factor (VEGF) with Src, RhoA, Rac1, and Cdc42 as crucial 
downstream components (Osiak et al., 2005; Wang et al., 2009). Finally, platelet 
derived growth factor (PDGF) induces podosome formation in VSMCs 
13 
 
(Quintavalle et al., 2011). 
Invadopodia are also induced by many of these growth factors and utilize 
the same downstream signaling pathways. EGF is a key signaling input for 
invadopodia formation in cancer cells. EGF stimulation induces actin 
polymerization at invadopodia sites through a well-defined pathway involving 
Nck1 and N-WASp (Yamaguchi et al., 2005; Mader et al., 2011). VEGF induces 
invadopodia in head and neck squamous cell carcinoma (HNSCC) cells (Lucas 
et al., 2010). Hepatocyte growth factor (HGF) and stromal cell derived factor 1 
alpha (SDF1α) increase breast cancer cell invadopodia formation through Src 
and cortactin or Abl kinases, respectively (Smith-Pearson et al., 2010; Rajadurai 
et al., 2012). TGF-β induces non-invasive mammary epithelial cells to produce 
invadopodia and degrade matrix through RhoC-ROCK, Rac1-p38MAPK 
signaling, the paxillin family member Hic-5, focal adhesion kinase (FAK), and Src 
signaling (Pignatelli et al., 2012), while TGF-β treatment of invasive cells 
enhances invadopodia formation through Src and PI3K and matrix degradation 
through extracellular signal-regulated kinases (ERK) signaling (Mandal et al., 
2008). These data indicate that many types of growth factor stimulation converge 
upon similar or identical signaling hubs for both invadopodia and podosome 
activity, including Src, PI3K and Rho family small GTPases. 
 
Lipid Regulation of Invadopodium and Podosome Formation 
 At numerous cellular sites, phosphatidylinositol lipids serve as critical 
activators of actin polymerization (Wennstrom et al., 1994; Ueno et al., 2011). 
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With respect to invadopodium and podosome formation, PI3K signaling was 
recently shown to be critical (Oikawa et al., 2008; Yamaguchi et al., 2011; 
Hoshino et al., in revision). Regulators of phosphatidylinositol phosphates (PIPs) 
have been implicated in the regulation of invadopodia and podosome formation. 
PI3Ks phosphorylate phosphatidylinositides at the D-3 position primarily creating 
PI(3,4,5)P3 (PIP3) from PI(4,5)P2 (Fruman et al., 1998). PI3Ks are activated 
downstream of a number of extracellular signals, especially downstream of 
growth factor receptor signaling (Cantley, 2002). Knockdown of class I PI3Ks 
reduces invadopodia number and degradation of ECM by a similar amount, 
suggesting a specific effect on invadopodia formation (Yamaguchi et al., 2011; 
Hoshino et al., in revision). Classic signaling downstream of PI3K involves 
phosphoinositide-dependent protein kinase 1 (PDK1)-mediated phosphorylation 
and activation of Akt serine-threonine kinases (Cantley, 2002). Indeed, both 
PDK1 and Akt were shown to be required for invadopodia formation in breast 
cancer cells and inhibition of each abrogates increased ECM degradation in 
response to constitutively active PI3K (Yamaguchi et al., 2011). PI3K inhibition 
also reduces podosome formation induced by phorbol ester treatment to activate 
protein kinase C (PKC) in epithelial cells (Xiao et al., 2012). These data suggest 
that PI3Ks may signal through a classical pathway to promote invadopodia and 
podosome formation, although the downstream mechanism is unclear. 
In addition to classic signaling via PIP3, it is possible that a critical function 
of PIP3 is to serve as a precursor lipid for PI3,4P2. Inositol polyphosphate 5-
phosphatases (5-ptases) such as SHIP2 or synaptojanin-2 (SJ-2) can form 
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PI(3,4)P2 from PIP3 (Ooms et al., 2009). SJ-2 is required for ECM degradation 
and localizes to invadopodia in glioma cells (Chuang et al., 2004) and is required 
for invadosome formation in Src-transformed fibroblasts (Oikawa et al., 2008). 
We also recently found that SHIP2 overexpression increases invadopodia 
formation and function dependent on PI3K activity (Hoshino et al., in revision). 
Interestingly, using specific PIP probes, Oikawa et al. demonstrated that 
PI(3,4)P2 is specifically localized at invadosomes while PIP3 localized to 
invadosomes but also to other areas in the cell (Oikawa et al., 2008). 
Overexpression of these probes sequesters the lipid, and the PI(3,4)P2 probe 
reduced invadosome number. Live cell imaging demonstrated that PI(3,4)P2 
clustering is an early event in invadosome formation following washout of the Src 
inhibitor PP2. These data suggest that PI(3,4)P2 is critical in the initial formation 
stage of invadosomes and invadopodia.  
Although few binding partners have been determined for PI(3,4)P2, the 
Src substrate Tks5 is a likely effector at invadosomes (Lock et al., 1998). Tks5 
preferentially binds to PI(3,4)P2 and PI(3)P, and its PX domain that mediates this 
binding is required for localization to invadosomes (Abram et al., 2003). Tks5 
localizes to invadopodia and podosomes and is required for ECM degradation in 
cancer cells and formation of podosomes (Seals et al., 2005; Crimaldi et al., 
2009). In non-tumorigenic cells, Tks5 is required for Src-induced invadosome 
formation, and Tks5 expression amplifies the invadopodia formation in cancer 
cells transfected with active Src (Seals et al., 2005; Stylli et al., 2009). Tks5 is 
believed to affect invadopodia/podosome formation in two ways. First, Tks5 can 
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form a complex with N-WASp and upstream scaffolding proteins Grb2 and Nck in 
response to Src activity in Src-transformed and cancer cells, respectively, to 
presumably promote actin polymerization at nascent invadopodia (Oikawa et al., 
2008; Stylli et al., 2009). Tks5 is also important for the generation of reactive 
oxygen species (ROS) downstream of active Src (Gianni et al., 2009).  ROS 
localize to and promote invadopodia and podosome formation, possibly by 
inactivation of the phosphatase PTP-PEST, which could otherwise inhibit Src 
activity (Diaz et al., 2009; Weaver, 2009). Thus, Tks5 may serve as both a 
scaffold protein and a feedback amplifier of Src signaling to facilitate the 
assembly of nascent invadopodia at PI3,4P2-rich membrane sites. Another 
possible effector which localizes to the plasma membrane via binding to 
PI(3,4)P2 and PIP3 is Akt. Akt was recently implicated in invadopodia and 
podosome formation (Yamaguchi et al., 2011; Xiao et al., 2012). Downstream 
effectors of Akt at invadopodia are unclear. However, PI3K-mediated Akt 
activation at the leading edge induces cell motility and actin re-organization, 
perhaps through phosphorylation of the actin-binding protein Girdin (Enomoto et 
al., 2005). 
Other PIPs have been localized to invadopodia and can regulate localized 
protein activation to promote actin assembly. PI(4,5)P2 surrounds the 
invadopodium protrusion and may be locally generated by phosphatidylinositol 4-
phosphate 5-kinase type I-alpha (PIP5KIα), which localizes to invadopodia in 
breast cancer cells (Yamaguchi et al., 2010). Both PI(4,5)P2 and PIP5KIα are 
required for ECM degradation by invadopodia, although invadopodia formation 
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itself was not assessed in that study (Yamaguchi et al., 2010). Interestingly, the 
Ras family GTPase Arf6, which activates PIP5KIα downstream of EGF (Honda et 
al., 1999), localizes to and is required for invadopodia activity (Hashimoto et al., 
2004; Tague et al., 2004). PI(4,5)P2 affects a wide range of actin regulators 
(Saarikangas et al., 2010). N-WASp, which promotes actin nucleation via 
activation of the Arp2/3 complex (Machesky et al., 1999), is activated by binding 
to PI(4,5)P2 and active Cdc42 (Rohatgi et al., 1999; Kim et al., 2000; Rohatgi et 
al., 2000). N-WASp localizes to invadosomes or podosomes in both Src-
transformed fibroblasts and macrophages as well as to invadopodia in its active 
form (Mizutani et al., 2002; Lorenz et al., 2004; Isaac et al., 2010). N-WASp 
knockdown or inhibition of its binding to the Arp2/3 complex reduces invadopodia 
or podosome formation, or ECM degradation by podosomes in macrophages 
(Mizutani et al., 2002; Yamaguchi et al., 2006; Nusblat et al., 2011). PI(4,5)P2 
also regulates the activity of Nck and Grb2, which are binding partners and weak 
activators of N-WASp (Rohatgi et al., 2001), and critical for invadopodia and/or 
podosome formation (Yamaguchi et al., 2005; Oikawa et al., 2008). 
 
Protease Trafficking is Crucial for Functionality of Invadopodia and Podosomes 
Cellular protein trafficking machinery is thought to be critical for polarized 
localization of proteins to invadopodia (Poincloux et al., 2009). Although the Golgi 
complex has been localized in close proximity to invadopodia (Baldassarre et al., 
2003) and was initially assumed to be the major source of secretory vesicles, 
recent data suggest that a late endosomal/lysosomal compartment is critical for 
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delivery of MT1-MMP (Steffen et al., 2008). Although MT1-MMP is probably 
initially exocytosed via the biosynthetic pathway from the Golgi, a large fraction of 
internalized MT1-MMP is recycled back to the membrane from endosomes and 
localizes with late endosome/lysosome markers. Endolysosomal recycling may 
provide a mechanism to relieve TIMP-2 mediated inhibition of MT1-MMP activity 
(Remacle et al., 2003; Itoh & Seiki, 2006; Li et al., 2008).  
Some components of the pathway regulating delivery of MT1-MMP to 
invadopodia have been identified. The exocyst complex consists of eight proteins 
and functions to tether post-Golgi and endocytic recycling vesicles to the plasma 
membrane (Prigent et al., 2003; Hsu et al., 2004). The exocyst plays a role in 
both invadopodia formation via the Arp2/3 complex (Liu et al., 2009a) and 
invadopodia function via MT1-MMP localization to invadopodia dependent on the 
polarity protein IQGAP (Sakurai-Yageta et al., 2008). Phosphorylation of the 
exocyst subunit Exo70 by ERK1/2 enhances exocytosis from the biosynthetic 
pathway as measured by vesicular stomatitis virus G glycoprotein (VSVG) 
exocytosis and partially regulates ECM degradation by invadopodia, suggesting 
a role for exocyst mediated post-Golgi vesicle docking in invadopodia function 
(Ren & Guo, 2012). However, the localization of VSVG as a measure of 
biosynthetic secretion at invadopodia has been controversial (Caldieri et al., 
2012). Therefore, MT1-MMP recycled through a late endosome/lysosome 
compartment may be the key population trafficked to invadopodia. In fact, 
bafilomycin treatment to inhibit the acidification of lysosomes reduces MT1-MMP 
accumulation at invadopodia as measured by fluorescence recovery after 
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photobleaching (FRAP) (Hoshino et al., 2012). Also, knockdown of the late 
endosomal/lysosomal vesicular N-ethylmaleimide-sensitive factor (NSF)-
attachment protein receptors (SNARE) VAMP7, which localizes to MT1-MMP-
containing vesicles, reduces MT1-MMP surface localization and invadopodia-
related degradation of the ECM by 60-70%, suggesting a prominent role for 
recycled MT1-MMP at invadopodia (Steffen et al., 2008). It is currently unclear, 
however, if exocyst- and VAMP7-mediated MT1-MMP localization on the cell 
surface are linked or receive MT1-MMP from different cellular trafficking 
pathways. The extracellular signals that induce MT1-MMP recruitment to 
invadopodia are also unclear. 
Cell-ECM adhesion has recently emerged as an important regulator of 
membrane trafficking. Loss of cell-ECM attachment results in internalization of 
raft domains dependent on caveolin-1 (Cav-1) (del Pozo et al., 2004; del Pozo et 
al., 2005), while reattachment induces recycling of lipid rafts from endosomes to 
the plasma membrane dependent on interaction of the small GTPases Arf6 and 
RalA with the exocyst complex (Balasubramanian et al., 2007; Balasubramanian 
et al., 2010). Intriguingly, Arf6 regulates ECM degradation by cancer cells 
(Hashimoto et al., 2004; Tague et al., 2004), while the exocyst affects MT1-MMP 
localization to invadopodia (Sakurai-Yageta et al., 2008). Invadopodia contain 
lipid raft components and Cav-1-containing vesicles dynamically traffic with MT1-
MMP (Yamaguchi et al., 2009). MT1-MMP also fractionates with lipid raft 
components (Yamaguchi et al., 2009; Grass et al., 2012). Cav-1 is also required 
for functional invadopodia formation and MT1-MMP overexpression-induced 
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increases in ECM degradation (Yamaguchi et al., 2009). Therefore, cell-ECM 
adhesion may play a key role in promoting exocytosis of lipid raft-rich vesicles 
containing MT1-MMP and other cargo. 
 
Adhesion Regulation of ECM Degradation by Cellular Organelles 
The main focus of the work in this dissertation is the regulation of 
invadopodia by cell-ECM interactions. Podosomes in normal cells are often the 
primary adhesion structures (Marchisio et al., 1984; Marchisio et al., 1987), while 
invadosome formation in Src-transformed cells or podosome formation induced 
by PKC activation adhesions leads to complete disassembly of FAs with 
recruitment of adhesion proteins to the new invadosome/podosome structures 
(Chen et al., 1984; Kaverina et al., 2003; Burgstaller & Gimona, 2004). 
Podosomes and invadosomes form specifically on adherent surfaces, and 
knockout of β1 integrins or activation of CD44 can reduce or increase the number 
of invadosome secondary rosette structures, respectively (Chabadel et al., 2007; 
Destaing et al., 2010). Interestingly, osteoclast podosome organization into belts 
and bone resorption, but not actin core formation, was reduced with 
combinations of β1, β2, and αV integrin knockout (Schmidt et al., 2011). 
Furthermore, podosome or invadosome rosette expansion, actin core turnover, 
and matrix degradation, but, again, not actin core formation, are affected by 
knockdown or perturbation of paxillin phosphorylation, FAK, p130Cas, RhoA-
ROCK signaling, and calpain (Berdeaux et al., 2004; Brabek et al., 2004; Calle et 
al., 2006; Tatin et al., 2006; Badowski et al., 2008; Pan et al., 2011). 
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Interestingly, these proteins have previously been shown to control focal 
adhesion turnover (Franco et al., 2004; Webb et al., 2004; Ezratty et al., 2005; 
Schober et al., 2007). These data implicate cell-ECM adhesion and downstream 
signaling in the turnover, expansion, and functionality, but not formation, of these 
structures.  
Focal adhesions have long been considered non-degradative structures 
that mediate attachment to the ECM and serve as signaling scaffolds (Geiger & 
Yamada, 2011). A recent study localizes degradation of a very thin ECM layer 
underneath FAs in a subset of fibrosarcoma and pancreatic cells dependent on 
MT1-MMP, Src, FAK and p130Cas (Wang & McNiven, 2012). Due to the 
increased sensitivity of this ECM degradation system compared to classic 
invadopodia assays, this study likely revealed a low level of degradative ability by 
FAs. Interestingly, these structures were determined to be separate from 
invadopodia, as the streak-like degradation underneath FAs was distinct from the 
dot-like invadopodia-related ECM degradation underneath the same cell. Src, 
FAK, and p130Cas inhibition or knockdown appeared to primarily affect FA-
related rather than invadopodia-related degradation in cells that exhibited ECM 
degradation underneath FAs. However, Src inhibition completely abolished ECM 
degradation in cells which form classic invadopodia, while FAK and p130Cas 
knockdown had no effect. These data suggest that FAK and p130Cas may 
specifically affect MT1-MMP recruitment to FAs. In certain physiological invasive 
situations, cells likely combine protrusive, invasive, and adhesive machinery 
(Friedl & Wolf, 2009; Gligorijevic et al., 2012). In fact, adhesions have been 
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observed in 3D and in vivo (Cukierman et al., 2001; Kubow & Horwitz, 2011), and 
β1 integrin has been localized with MT1-MMP and degraded collagen at the base 
of cellular protrusions in 3D (Wolf et al., 2007). Therefore, adhesion-mediated 
protease recruitment is an attractive model to facilitate cellular invasion in 
physiologic environments. 
The role of FA proteins at or around invadopodia has been controversial 
(Linder et al., 2011; Murphy & Courtneidge, 2011). Initial studies demonstrated 
localization of α3, β1 integrin, and paxillin at invadopodia and α5β1 around the 
protrusion in melanoma or breast cancer cells (Bowden et al., 1999; Mueller et 
al., 1999) with ligation of β1 integrin increasing ECM degradation underneath 
these cells (Nakahara et al., 1996; Nakahara et al., 1998). However, in rat 
bladder carcinoma cells, antibody blocking of α3 or β1 integrin increased 
invadopodia formation, potentially by blocking binding to laminin-332, which 
these cells secrete liberally (Liu et al., 2009b). Downstream of integrins, 
knockdown or inhibition of FAK activity was shown to increase invadopodia 
numbers (Chan et al., 2009; Liu et al., 2009b), perhaps by releasing retention of 
Src kinase at competing FAs. However, other studies have shown a requirement 
for FAK in invadopodia-associated matrix degradation downstream of 
p190RhoGEF or an increase in matrix degradation with FAK overexpression 
(Alexander et al., 2008; Yu et al., 2011; Pignatelli et al., 2012). Altogether, the 
localization and effect of adhesion proteins at invadopodia remains an open 
question, especially given the coincident expression of focal adhesions in the 
same cancer cells that form invadopodia.  The relative lack of live imaging 
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studies has also made it difficult to distinguish at which stage adhesion proteins 
act to regulate invadopodia and podosome formation and/or function. 
 
Purpose of this study 
The BM and surrounding stromal ECM are often viewed as a barrier to 
tumor cell invasion. However, chemical and physical signals from the ECM can 
be sensed by the cell and transmitted into biochemical responses. Tumors are 
often associated with an increase in tissue rigidity due to proliferation and 
packing of tumor cells against the surrounding BM as well as the desmoplastic 
response, which involves increased collagen deposition in the immediate tumor 
environment (Li et al., 2005). Interestingly, increased breast density associated 
with collagen deposition is a prognostic indicator of breast tumor development 
and invasive capacity (Boyd et al., 2005; Gill et al., 2006). In vitro studies have 
demonstrated a progressively invasive phenotype in tumor cells grown in 3D 
environments of increasing rigidity (Paszek et al., 2005; Provenzano et al., 
2008a). However, when this study began, it was unclear by what cellular 
mechanisms tissue rigidity might promote invasive behavior. 
These studies tested the hypothesis that cell-ECM interactions promote 
the maturation of invadopodia to fully functional, ECM degrading structures. This 
work demonstrates that invadopodia-associated ECM degradation is modulated 
by substrate stiffness and the stiffness with maximum activity can vary depending 
on tumor cell type. Overexpression of the mechanosensing proteins FAK and 
p130Cas can augment the invadopodial response to stiffness. 
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In addition, integrins, which are key receptors for ECM, are investigated as 
promoters of invadopodia formation and function. Adhesion proteins were found 
to distinctly localize in ring-like structures around invadopodia. Inhibition of 
integrins with either a blocking antibody or by use of a peptide inhibitor of ECM-
integrin interaction specifically affected cellular ECM degradation by reducing 
MT1-MMP recruitment to invadopodia. This process requires the integrin effector 
integrin-linked kinase (ILK) and apparently involves downstream recruitment of 
the scaffold protein IQGAP. These data support a model in which cell-ECM 
interactions specifically promote the maturation stage of invadopodia to promote 






MATERIALS AND METHODS 
 
Antibodies and reagents 
 
Antibodies 
Cortactin, 4F11, FAK, clone 4.47 (Upstate Biotechnology, Lake Placid, NY); non-
muscle myosin IIA, IIB, β-actin, AC-74, and vinculin, hVin-1 (Sigma, St. Louis, 
MO); p130Cas (clone 21, BD Biosciences, San Jose, CA); phosphorylated serine 
19-myosin light chain 2 (pMLC), Src pY416, #2101, GAPDH, 14C10, and pY165-
p130Cas (Cell Signaling, Danvers, MA); pY397 FAK (BioSource, Carlsbad, CA); 
Paxillin (Y113, Abcam, Cambridge, MA); IQGAP, H-109, normal mouse IgG, and 
integrin β1, active, 12G10, (Santa Cruz, Santa Cruz, CA); integrin β1, blocking, 
AIIB2 (a gift from Dr. Roy Zent, Vanderbilt University); integrin αVβ3, blocking, 
LM609 (Millipore, Billerica, MA); and fluorescent Alexa Fluor secondary 
antibodies and phalloidin (Invitrogen, Grand Island, NY).  
 
Reagents 
Blebbistatin, ML-7, and Y-27632 were from Calbiochem (Merck KGaA, 
Darmstadt, Germany). Gly-Arg-Gly-Asp-Ser-Pro (GRGDSP, Sigma), and Gly-
Arg-Gly-Glu-Ser-Pro (GRGESP, American Peptide Co., Sunnyvale, CA). 
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tdTomato-F-tractin (Tom-Tract) was a gift of Dr. Robert Fischer (NHLBI, 
Bethesda, MD) and was created by cloning the 9-52 stretch of the F-actin binding 
protein ITPKA (Johnson & Schell, 2009) into pCMV-tdTomato (Clontech, 
Mountain View, CA). GFP-paxillin was PCR cloned from pEGFP-N3-Paxillin, a 
gift of Dr. Donna Webb (Vanderbilt), into the pENTR-TOPO vector and 
recombined into the LZRS-GW-Neo retroviral vector, a gift from Dr. Al Reynolds 
(Vanderbilt), using the Gateway recombination system (Invitrogen). LZRS-MS-
Cas and LZRS-MS-FAK were gifts from Dr. Steven Hanks (Vanderbilt). MT1-
MMP-pHLuorin (MT1-pHLuor) was a gift from Dr. Philippe Chavrier (Institut 
Curie, Paris). MT1-pHLuor was PCR-cloned into the pLenti6 lentiviral vector by 
Dr. Daisuke Hoshino (Invitrogen). Control (non-targeting shRNA (NTC), 
Addgene, Cambridge, MA) and two shRNA constructs targeting ILK (sh1- 5’- 
CUGAACAAACACUCUGGCAUU -3’ (Thermo Scientific, Lafayette, CO), sh2- 5’- 
GCAAUGACAUUGUCGUGAAGG -3’ (Sigma)) were obtained in the lentiviral 
vector pLKO.1-puro (Sigma). MT1-MMP targeting shRNA (MT1 sh1- 5’- 
CAGCGATGAAGTCTTCACTTA -3’, sh2- 5’-CAGCCTCTCACTACTCTTTC -3’) 
or shLacZ as a control were subcloned into the lentiviral vector pLenti-BlockIt by 
Dr. Daisuke Hoshino (Invitrogen). 
 
Cell Culture and Manipulation 
 
Cell Culture 
MCF10A-CA1d breast cancer cells were obtained from Dr. Fred Miller 
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(Karmanos Institute, MI) (Santner et al., 2001). Cells were cultured in DMEM/F12 
supplemented with 5% horse serum (HyClone, Thermo Scientific), 0.1 ug/ml 
cholera toxin (Calbiochem), 10 ug/ml insulin (Gibco, Invitrogen), 0.5 ug/ml 
hydrocortisone (Sigma), and 20 ng/ml EGF (Invitrogen) at 37° C with constant 
humidity. SCC61 HNSCC cells were previously described (Weichselbaum et al., 
1986) and were cultured in DMEM supplemented with 20% fetal bovine serum 
(FBS, HyClone) and 0.4 mg/ml hydrocortisone (Sigma) at 37° C. 
 
Transfection and Transduction 
Tom-Tract was transiently transfected into SCC61 cells at a 1:1 µg DNA:µl 
Lipofectamine 2000 (Invitrogen) ratio for 6 hours per the manufacturer’s 
instructions. Cells were imaged 1-2 days later. Retrovirus or lentivirus were 
produced using Phoenix (Dr. Garry Nolan, Stanford) or 293FT cells, respectively, 
and SCC61 cells were incubated with viral supernatant overnight and later 
selected with the appropriate antibiotics.  
 
Invadopodia Assay 
MatTek culture dishes pre-coated with poly-D-lysine (PDL) (MatTek Corp., 
Ashland, MA) were coated with 1% gelatin + 1% sucrose (different percentages 
are noted for Figure 2) in PBS for 1 minute. The gelatin was then wicked away 
until only a very thin layer remained, which was allowed to dry at a >70° angle for 
45 minutes. The gelatin was then crosslinked with 0.5% glutaraldehyde for 15 
minutes on ice followed by 30 minutes at room temperature. Glutaraldehyde was 
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then deactivated with 1 mg/ml sodium borohydride for 3 minutes. Then, the gels 
were coated with 50 µg/ml FITC-conjugated fibronectin (FITC-FN). Finally, dishes 
were sterilized with 70% ethanol. Cells were cultured at a density to allow single 
cells (i.e. 25,000 in a 35mm dish) in a 1:1 ratio of DMEM:RPMI-1640 (or L-15 for 
live cell imaging) with 5% NuSerum (Gibco), 10% FBS, and 100 ng/ml EGF for 
20 hours before fixation with 4% paraformaldehyde and immunostaining. For 
integrin-blocking studies, RGD, RGE (250 µg/ml), or specific integrin blocking 
antibodies (10 µg/ml each) were added immediately upon plating of the cells. 
 
Fluorescent-FN Conjugation 
6 mg fluorescein isothiocyanate isomer I (FITC, Sigma) was dissolved in 200 ml 
borate buffer. FN was diluted to 0.5 mg/ml in 10 ml borate buffer in a dialysis 
bag. FN was then placed in the FITC-borate buffer solution in the dark at room 
temperature with spinning for 1.5 hours. To remove un-conjugated FITC, the now 
FITC-labeled FN was dialyzed against PBS for 2-3 days with 3 changes per day 
at 4° C. The concentration of labeled FITC-FN was determined by measuring the 
optical density (OD) of the FITC-FN at 280nm and 493nm. The protein 
concentration was determined with the following equation: FITC-FN (mg/ml) = 
[OD280 – (0.36 x OD493)] / 1.34. If a fluorescent protein with an ester attacking 
group was used to label FN (i.e. Alexa Fluor 633 succinimidyl ester), then 0.2M 





3-aminopropyltrimethoxysilane functionalized MatTek dishes were coated with 
polyacrylamide (PA) gels (Pelham & Wang, 1997). The gels used contained 8% 
acrylamide and 0.05% bis-acrylamide (soft) or 0.35% bis-acrylamide (hard). The 
thin (~75 µm) PA gels were coated with gelatin (~1 µm thickness) and FITC-FN 
and cells were cultured as outlined for the invadopodia assay. 
 
Rheology 
Gelatin and PA gels (both hard and soft) were analyzed on a TA Instruments 
ARG2 rheometer at 37°C using a 25 mm circular head. Strain sweeps were first 
performed at 1 Hz to identify the range where the storage modulus was constant 
as a function of strain, which ranged from 0.025 to 0.1% depending on the 
material. Frequency sweeps (0.1 – 10 Hz) were then performed for each material 
at constant applied strain. Storage modulus data reported were measured at 1 
Hz. 
 
Microscopy and Analysis 
 
Immunofluorescence 
CA1d and SCC61 cells plated for invadopodia or adhesion analyses were fixed 
with 4% paraformaldehyde (Avantor, Center Valley, PA), permeabilized with 
0.5% Triton X-100 (Research Products International Corp., Mt. Prospect, IL), 
blocked for 1 hour with 3% bovine serum albumin fraction V (BSA, Merck KGaA), 
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incubated with indicated primary antibodies in 3% BSA for 1 hour or overnight 
followed by appropriate fluorescently-conjugated secondary antibodies, or 
fluorescently-labeled phalloidin to mark actin filaments, for 1 hour in 3% BSA. 1x 
PBS was used for all washes. Imaging was performed as detailed below. 
 
Polyacrylamide Gel Invadopodia Analysis, Widefield 
Widefield fluorescent images were captured on a Nikon Eclipse TE2000-E 
microscope with a 40X Plan Fluor oil immersion objective lens. Degradation area 
per cell was determined using MetaMorph software (Molecular Devices, 
Sunnyvale, CA) by tracing a region around the cellular actin footprint and 
measuring the thresholded area of dark spots in the FITC-FN in that region. 
Functional invadopodia were manually counted as morphologically characteristic 
round actin or cortactin puncta ≥1 µm in diameter found at the basal surface of 
the cell which also localized with dark holes in the FITC-FN (Clark et al., 2007a). 
 
Adhesions and Invadopodia Analyses, Confocal 
Fixed cell confocal images were taken using a Zeiss LSM 510 microscope with 
the pinhole set at 1 Airy unit, with a Plan Apo 63X oil immersion objective lens 
with Argon-488nm, HeNe-543nm, and HeNe-633nm lasers. Images were taken 
at a scan speed of 8 and 4 scans were averaged per acquisition. Degradation 
areas per cell and invadopodia numbers were determined as above. If ECM 
degradation was associated with an invadopodia, it was classified as “active”; 
otherwise it was classified as “inactive”. The presence of an adhesion ring was 
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defined as paxillin or vinculin fluorescence above background surrounding the 
invadopodia.  Invadopodia metrics (adhesion ringed, non-ringed, total, active and 
inactive invadopodia) were manually counted. For focal adhesion analyses on 
paxillin-immunostained cells, the central region of the cell with high background 
cytoplasmic fluorescence was excluded and the remaining periphery was 
thresholded.  The number and area of peripheral focal adhesions per cell was 
then determined with the “Analyze Particles” function in ImageJ (NIH). For 
IQGAP localization analyses, SCC61 cells were plated on invadopodia 
substrates and fixed and stained for actin and IQGAP. Images were obtained 
with the Zeiss LSM 510 confocal as described above. The pinhole was opened 
slightly (1.4 µm optical slice) to account for the slightly higher Z-axis localization 
of IQGAP at invadopodia. Equal laser power, digital gain and offset settings were 
used in each experiment and actin and IQGAP signals were within the dynamic 
range. Invadopodia were traced using the actin immunostaining and average 
intensity of the actin and IQGAP signals within the traced regions was obtained 
using ImageJ. Linescans were created with Metamorph. Confocal Z-slices were 
taken at 0.05 µm per slice for FAK and Cas and 0.1 µm per slice for IQGAP. 
 
Live Cell Imaging 
For adhesion ring imaging, live cell confocal images of SCC61 cells stably 
expressing GFP-Paxillin and transiently transfected with Tom-Tractin were taken 
using a Zeiss LSM 710 confocal microscope with the pinhole set at 1 Airy unit, 
with a Plan Apo 63X oil immersion objective lens with Argon-488nm and HeNe-
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561nm lasers. Time-lapse images were obtained every 15 seconds at a scan 
speed of 8 with 4 images averaged per acquisition. Time of invadopodia and 
paxillin ring appearance was manually determined. For invadopodia and MT1-
MMP imaging with Tom-Tractin alone or with MT1-pHLuorin, an Applied 
Precision DeltaVision Core microscope with a Plan Apo 60X oil immersion 
objective lens was used. SCC61 cells expressing Tom-Tractin and/or MT1-
pHLuorin, with ILK-KD or NTC shRNA where noted, were seeded in the ECM 
degradation assay on 1% gelatin/unlabeled-FN and placed in a heated 
microscope chamber at 37°C 2 hours prior to imaging. When used, RGE or RGD 
peptides were added at the time of cell seeding. Images were then obtained 
every 15 seconds and processed with 10 iterations of constrained iterative 
deconvolution using Softworx 5.0 (Applied Precision, Issaquah, WA). For live-cell 
invadopodia analyses, the actin-containing invadopodia were traced at their 
largest area and fluorescence intensity of Tom-Tract and MT1-pHLuorin was 
determined at each time point using Metamorph. The Tom-Tract and MT1-
pHLuorin signal at each time point was background corrected at each 
invadopodia with an identical traced region placed in a similar area of the cell but 
lacking an invadopodium. With these data, invadopodia formation rate, lifetime, 
and MT1-pHLuorin accumulation at invadopodia were determined as described 






Data sets were tested for normality using the Kolmogorov-Smirnov normality test 
in GraphPad InStat3 (GraphPad Software, La Jolla, CA). Groups of non-normal 
data were compared using the Mann-Whitney rank sum test, while parametric 
data were compared with an unpaired t-test. Non-normal data were plotted as 
box and whiskers, which show respectively the 25-75th and 5-95th percentiles 
with the dotted red line indicating the mean and the black line indicating the 
median. For the Spearman rank analysis, comparisons between degradation 
area/cell and each other data set were performed in GraphPad InStat3. A perfect 
positive correlation = 1, no correlation = 0 and a perfect negative correlation = -1, 





SUBSTRATE RIGIDITY PROMOTES INVADOPODIA ACTIVITY 
 
Introduction 
Tumor metastasis is a leading cause of mortality from cancer due to an 
increased tumor load at multiple sites in the body. An initial step in metastasis is 
invasion of cancer cells from the primary tumor site, which is often surrounded by 
a dense BM. Proteolytic degradation is required to breach the BM and allow cell 
invasion beyond the primary site (Hotary et al., 2006). In fact, loss of BM 
surrounding the tumor is observed in aggressive versus benign tumors (Barsky et 
al., 1983).  
Although the BM and surrounding ECM are often viewed as barriers to 
cancer progression, cancerous phenotypes can be promoted by physical and 
chemical signals from the ECM. The physical stiffness of the ECM in particular 
can affect tumor progression. High mammographic density is a strong prognostic 
indicator for breast tumor formation and progression (Boyd et al., 2005; Gill et al., 
2006). An increase in collagen deposition in the surrounding environment is also 
associated with tumor development (Li et al., 2005). Therefore, physical signals 
from the ECM may promote cancer cell invasiveness. 
Cells are known to sense mechanical signals from the surrounding 
environment via integrin-actomyosin interactions at FA through a process termed 
mechanotransduction. Forces are transmitted into the cell via contraction of non-
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muscle myosin II (MyoII) to generate intracellular tensile forces (Giannone & 
Sheetz, 2006; Clark et al., 2007b). Cells respond to extracellular forces at the 
protein level to elicit a number of cellular responses. At the protein level, 
stretching of purified FA proteins talin or Cas induce binding to vinculin or 
extensive tyrosine-phosphorylation, respectively (Sawada et al., 2006; del Rio et 
al., 2009). FAK may also unfold to induce paxillin binding (Mofrad et al., 2004). At 
the cellular level, fibroblasts preferably migrate toward stiffer matrices dependent 
on FAK auto-phosphorylation at Y397 (Wang et al., 2001), while phosphorylation 
at Y397 increases in cells on stiffer matrices (Paszek et al., 2005). Increasing 
rigidity also results in a more dispersed and migratory phenotype in fibroblasts 
with fewer aggregations similar to a model of epithelial-to-mesenchymal 
transition (Guo et al., 2006). In vitro studies have demonstrated an increasingly 
invasive phenotype in breast cancer cells growing in increasingly stiff 3D 
collagen I gels (Paszek et al., 2005). The cellular mechanism for increased 
cancer cell invasion in response to stiffness is unknown, however. 
Invadopodia are sub-cellular, actin-rich, protrusive structures important for 
cancer cell invasion. Invadopodia localize actin polymerization machinery and 
protease activity to locally degrade and invade ECM (Weaver, 2006). Formation 
of invadopodia by cancer cells often correlates with tumor aggressiveness in in 
vivo models (Coopman et al., 1998; Bowden et al., 1999). Despite close ECM 
contact, it is unclear how chemical or physical signals from the ECM affect 
invadopodia. 
In this chapter, we demonstrate that invadopodia activity is enhanced by 
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increasing substrate rigidity. The degradation of ECM by invadopodia is 
dependent on MyoII activity. MyoIIA localized in rings surrounding a subset of 
invadopodia, highlighting an area where mechanosensing may occur. Over-
expression of proteins known to be involved in mechanosensing, FAK and Cas, 
primed the invadopodial response to rigidity and increased degradation of the 




ECM Rigidity Promotes Invadopodia Activity 
 We first tested the role of ECM density on invadopodia function. MCF10A 
CA1d invasive breast cancer cells were cultured on increasing concentrations of 
gelatin from 0.5% - 5% which was overlaid with fluorescently-labeled FN (FITC-
FN) to visualize degradation by invadopodia. Rather than acting as an increasing 
barrier to invasion, high concentrations of gelatin promoted degradation of FITC-
FN (Fig. 2A). The degradation area per cell was quantified and increased with 
higher concentrations of gelatin, with the largest increase between 2.5% and 5% 
(Fig. 2B, black line). The number of functional invadopodia per cell, measured as 
actin puncta co-localized with degradation of FITC-FN, increased similarly to the 
degradation area (Fig. 2B, red line). Increasing the density of gelatin gels is likely 
to increase their rigidity. Therefore, we performed rheology with an oscillatory 
shear deformation of the gelatin gels to obtain their storage modulus. The 






and, again, the largest increase occurred between 2.5% and 5% gelatin (Fig. 2B-
C). These data suggest a causal relationship between gelatin concentration and 
degradation of ECM by invadopodia. 
While increasing the gelatin concentration increases the rigidity of the 
gels, it also serves to increase the ECM ligand availability, which can affect 
phenotypes such as cell spreading (Engler et al., 2004). Therefore, we cast two 
different stiffnesses of PA gels by altering the amount of bis-acrylamide cross-
linker (Pelham & Wang, 1997) and coated them with an equal concentration of 
gelatin (1%), which was then overlaid with FITC-FN to visualize degradation. 
When measured by rheology, the storage modulus of the “soft” and “hard” PA 
gels were 360 and 3300 Pascals (Pa), respectively (Fig. 3A). These values are 
on the order of magnitude of measured values in a mouse normal mammary 
gland compared to a mammary tumor (Paszek et al., 2005). Interestingly, the 
degradation of FITC-FN underneath the cells increased on the hard gels 
compared to the soft (Fig. 3B, C). Coating the PA gels with gelatin alone or 
gelatin/FN had little effect on the storage modulus (Fig. 3A). Cells cultured on the 
PA gels were immunostained for cortactin and actin, as co-localization of these 
two proteins with degradation of the underlying ECM represents a functional 
invadopodium. An increase in functional invadopodia per cell was observed on 
the hard PA gels (Fig. 3D). Matrix stiffness can enhance invadopodia activity 
across a variety of cancer cell lines, as these effects were also observed in 
SCC61 HNSCC and 804G rat bladder carcinoma cells (Fig. 3E-H). These data 






Myosin II Contractility is Required for Invadopodia Functionality 
 Because cells sense the rigidity of the surrounding environment via 
integrin-actomyosin interactions at the cell surface, we then wanted to test the 
role of MyoII contractility in invadopodia activity. Therefore, we treated CA1d 
cells in a dose-dependent manner up to 25 µM with the specific MyoII inhibitor 
blebbistatin (Straight et al., 2003), an inhibitor of the upstream activator of MyoII, 
myosin light chain kinase (MLCK) (ML-7) (Saitoh et al., 1987; Vicente-
Manzanares et al., 2009), or an inhibitor of Rho-associated kinase (ROCK, Y-
27632) (Uehata et al., 1997), which can act upstream of MyoII through a variety 
of pathways (Vicente-Manzanares et al., 2009). In all three cases, there was a 
significant dose-dependent decrease in degradation area per cell (Fig. 4A-B). 
Interestingly, the proportion of functional to total invadopodia was decreased with 
blebbistatin or ML-7 treatment (Fig. 4C). In fact, in blebbistatin treated cells, the 
total number of invadopodia increased while the functional invadopodia 
decreased (Fig. 4C). Confocal Z-analysis revealed that, in comparison to control 
DMSO, blebbistatin treated cells formed a large number of actin puncta that were 
not protrusive or degradative into the ECM (Fig. 4D-E). These actin puncta could 
represent early invadopodia precursors. This suggests that MyoII contractility in 
response to substrate rigidity specifically induces the maturation of invadopodia 
rather than their formation.  
Immunofluorescence studies were then performed to determine the 
localization of MyoII in relation to invadopodia. Although MyoII was important in 










observed at the invadopodia puncta (Fig. 5). In fact, there was a noticeable lack 
of immunofluorescence for all three proteins at the puncta. Interestingly, ~40% of 
the cells with invadopodia presented with rings of MyoIIA immunostaining 
surrounding at least one invadopodium (Fig. 5A, yellow arrow, zoom), while 
MyoIIB or pMLC did not demonstrate this localization (Fig. 5B-C, red arrows). 
This localization is reminiscent of rings of adhesion proteins that form 
surrounding the actin cores of podosomes (Marchisio et al., 1984; Marchisio et 
al., 1987) and suggests a possible localization of MyoII contraction to affect 
invadopodia function. Regardless, MyoII contraction does not occur at the 
invadopodia puncta itself, but can still affect invadopodia function. 
 
FAK and Cas Prime the Rigidity-related Invadopodia Response 
 FAK and Cas are proteins known to be involved in transmitting mechanical 
force signals into cellular responses (Wang et al., 2001; Mofrad et al., 2004; 
Sawada et al., 2006). Therefore, we first immunostained for phosphorylated 
forms of FAK and Cas, specifically phospho-Y397FAK and phospho-Y165Cas, 
since each of these sites exhibits increased phosphorylation in response to 
mechanical force (Paszek et al., 2005; Sawada et al., 2006). Both pY397 FAK 
and pY165Cas localized at the actin puncta of the invadopodia as well as at FA 
(Fig. 6A-B). Each phospho-protein localized throughout the invadopodial 
protrusion by confocal Z-stack analysis (Fig. 6A-B). Furthermore, 
immunofluorescence with antibodies against total FAK or Cas also showed 









sometimes weaker at the invadopodia and also occasionally surrounded the 
puncta instead (Fig. 6C-D, yellow arrows). These proteins clearly localize at 
invadopodial structures distinct from classic FA which do not localize with 
degradation of the FITC-FN matrix (Fig. 6C-D, red arrows). 
 We hypothesized that these phosphorylation events on FAK and Cas 
occurred downstream of substrate rigidity sensing dependent on MyoII 
contractility. Therefore, we measured the intensity of pY397 FAK or pY165 Cas 
immunostaining specifically at functional and non-functional invadopodia with 
blebbistatin or ML-7 treatment to inhibit MyoII contractility (Fig. 6E). Interestingly, 
in the control DMSO condition, functional invadopodia exhibited a higher intensity 
of both pY397 FAK and pY165 Cas staining compared to non-functional 
invadopodia, suggesting a role for these phosphorylation events in the 
maturation of an invadopodium (Fig. 6E). Inhibition of MyoII contractility also 
decreased the fluorescent intensity of pY165 Cas and pY397 FAK at 
invadopodia, specifically at those few invadopodia that degraded the underlying 
matrix with MyoII inhibition (Fig. 6E). Meanwhile, no significant change was 
observed at non-functional invadopodia, although this may be due to the low 
levels of localization already observed at non-functional invadopodia without drug 
treatment (Fig. 6E). 
 To further test the roles of FAK and Cas in the invadopodia response to 
mechanical signals, we over-expressed (OE) each protein 3-4 fold in the CA1d 
cells (Fig. 6F). These cells were then cultured overnight on the soft and hard PA 
gels with fluorescent matrix to assess invadopodia activity. Interestingly, OE of 
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either protein only slightly increased the amount of degradation underneath the 
cells cultured on the soft PA gels (Fig. 6G). However, increased FAK or Cas 
expression each increased the amount of degradation area per cell on the hard 
PA gels, with Cas OE having a greater effect, perhaps due to increased protein 
levels compared to FAK OE (Fig. 6G). These data suggest that the 




 These results indicate that cellular degradation of the ECM is regulated by 
the physics of the surrounding environment. Because MyoII does not localize to 
the invadopodial protrusion, rigidity sensing does not appear to occur there. 
However, a subset of invadopodia exhibit MyoIIA ring localization surrounding 
the invadopodia puncta. This MyoII could represent a structure that can transmit 
ECM rigidity responses resulting in a local increase in invadopodia function. 
Contractile forces can also be transmitted long distances across the cell via 
cellular actin fibers attached to FA. In fact, activation of Src kinase occurs locally 
and at distal areas of the cell in response to forces applied to a FN-coated bead 
attached to the cell, dependent on intact microtubules and actin filaments (Wang 
et al., 2005). Therefore, FAK or Cas may be activated at invadopodia via whole-
cell, distant, or local rigidity sensing. Alternatively, FAK or Cas may be activated 
elsewhere and transported to the invadopodia site to promote maturation. 
 In many cell types, FA are regarded as the primary mechanosensing sites 
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where actin fibers connect to integrin-ECM adhesions via a myriad of signaling 
and scaffolding proteins such as talin, vinculin, paxillin, Src kinase, FAK, and Cas 
(Katsumi et al., 2004). Meanwhile, normal cells that traverse ECM or cell 
monolayers as part of their normal function use podosomes as a primary 
adhesive structure that also degrades underlying matrix (Gaidano et al., 1990; 
Burns et al., 2001; Hai et al., 2002; Moreau et al., 2003). Podosomes exhibit a 
well-characterized adhesion ring surrounding the actin core and podosome 
dynamics are altered by substrate rigidity as well (Collin et al., 2006). In fact, 
podosomes were recently demonstrated to be mechanosensors themselves 
(Collin et al., 2008). While invadopodia and podosomes share many 
components, the role of adhesion proteins in invadopodia activity is not well 
characterized (Mueller & Chen, 1991; Bowden et al., 1999; Deryugina et al., 
2001). Interestingly, Cas is required for invadosome formation, Matrigel invasion, 
and lung metastasis in Src-transformed fibroblasts (Brabek et al., 2004; Brabek 
et al., 2005). The Cas substrate domain tyrosines, which are increasingly 
phosphorylated in response to stretch (Sawada et al., 2006), are required for 
these Src-induced phenotypes (Brabek et al., 2005). FAK has long been linked to 
invasive phenotypes in cancer (Weiner et al., 1993; Owens et al., 1995) and may 
play a role in cellular invasion downstream of active Src (Hauck et al., 2002). We 
demonstrate a role for FAK in transmitting rigidity signals for increased 
invadopodia function. However, the role of FAK at invadopodia has since been 
controversial. FAK knockdown or inhibition of phosphorylation at Y397 increases 
invadopodia formation and activity on glass coverslips coated with gelatin and 
49 
 
FN, presumably by releasing Src from FA to create more invadopodia (Chan et 
al., 2009; Liu et al., 2009b). FAK has also been shown to weakly or possibly only 
transiently localize to invadopodia (Bowden et al., 2006). Therefore, FAK may 
play differing roles in invadopodia activity dependent on substrate rigidity. 
Because FAK and Cas OE can enhance the rigidity-induced invadopodia 
response and phosphorylation of FAK and Cas at invadopodia is affected by 
MyoII inhibition, rigidity signals from the ECM may be an important input to these 
mechanosensing proteins to promote invasion. Other FA proteins, such as talin, 
vinculin, and integrins themselves, are affected by tension or ECM rigidity at FAs 
(del Rio et al., 2009; Friedland et al., 2009; Kong et al., 2009; Pasapera et al., 
2010). Therefore, it is likely that other proteins also regulate cellular invasion in 
response to physical signals. 
 Many cancer phenotypes are regulated by the physical cues in the 
surrounding environment. Increased mammographic density is a risk factor for 
tumor incidence and aggressiveness (Boyd et al., 2005; Gill et al., 2006). 
Increased collagen deposition in the tumor microenvironment leads to increases 
in local stiffness and enhanced tumor invasion (Li et al., 2005; Provenzano et al., 
2008a). These data provide a novel mechanism for increased degradation of the 










 An increasing number of studies demonstrate that deregulated cell-ECM 
signaling promotes multiple phases of tumor progression from initiation to 
metastasis (Stewart et al., 2004; Lahlou & Muller, 2011). A key step in the 
progress of a tumor to metastasis that is driven by ECM attachment is cancer cell 
invasion, which involves regulation of cell motility and degradation of the ECM 
(Guo & Giancotti, 2004). ECM degradation is especially important, as cells 
cannot cross the highly cross-linked BM that surrounds the primary tumor without 
degradation and remodeling (Hotary et al., 2006; Parekh & Weaver, 2009). 
 Invadopodia are key cellular processes that can carry out this degradation 
of ECM and further protrude and invade the degraded areas (Chen, 1989; 
Schoumacher et al., 2010). Membrane-tethered (MT) proteases are critical for 
invasion through BM (Hotary et al., 2006; Rowe & Weiss, 2008). MT1-MMP is a 
MT protease critical for invadopodia activity (Nakahara et al., 1997; Sabeh et al., 
2004). Live cell imaging demonstrates a rapid localization of MT1-MMP to 
invadopodia shortly after invadopodia formation (Artym et al., 2006; Artym et al., 
2009). Recent studies have shed light on polarized delivery mechanisms leading 
to MT1-MMP localization to invadopodia (Poincloux et al., 2009). MT1-MMP is 
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trafficked from a late endocytic/lysosomal compartment dependent on the 
vesicular SNARE VAMP7, the scaffold protein IQGAP, and the exocyst complex 
(Sakurai-Yageta et al., 2008; Steffen et al., 2008; Hoshino et al., 2012). 
 In the previous chapter, I demonstrated that the chemical composition and 
physical rigidity of the ECM regulate the activity of invadopodia. I also implicated 
MyoII contractility in the maturation of invadopodia. Meanwhile, integrins and 
downstream signaling proteins have been shown to either promote or disrupt 
invadopodia formation (Nakahara et al., 1998; Chan et al., 2009; Liu et al., 
2009b). The formation or stability of invadosomes in Src-transformed cells is 
affected by integrin blocking as well (Badowski et al., 2008; Destaing et al., 
2010). Alternatively, integrin attachment to ECM proteins also promotes MT1-
MMP trafficking directly to the attachment site (Galvez et al., 2002; Bravo-
Cordero et al., 2007), and integrins have been suggested to play a role in 
protease docking at invadopodia (Mueller et al., 1999). We and others have 
observed adhesion protein localization, including MyoII (Figure 5), FAK (Figure 
6), RhoC (Bravo-Cordero et al., 2011), and α5 integrin (Mueller et al., 1999) at or 
surrounding invadopodia, similar to structures seen in podosomes (Linder & 
Aepfelbacher, 2003; Gimona et al., 2008). However, the presence of adhesion 
proteins at or around invadopodia remains controversial and this localization is 
suggested to be a defining difference between invadopodia and podosomes 
(Linder et al., 2011; Murphy & Courtneidge, 2011). Unlike podosomes in normal 
cells, cancer cells also interact with the ECM via FA that may compete with 
invadopodia for signaling proteins (Chan et al., 2009) or transmit signals from a 
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distance to affect invadopodia formation and function (Wang et al., 2005). 
Therefore, whether invadopodia act as adhesive structures is unclear and the 
role of integrin-ECM adhesion in invadopodia progression remains to be seen. 
This chapter will describe the characterization of invadopodia as adhesion 
structures and the role of a subset of integrins and downstream signaling 




Podosome-like Adhesion Rings Surround Invadopodia and Correlate with Their 
Activity 
FAs are important mechanosensing structures in the cell and Chapter III 
demonstrates that invadopodia activity is promoted by extracellular rigidity. 
However, invadopodia have been shown to compete with FAs for components 
(Chan et al., 2009). Therefore, I characterized the invadopodia and adhesion 
phenotypes in CA1d breast cancer and SCC61 HNSCC cells cultured on soft and 
hard PA gels as well as 1% gelatin/FITC-FN on a glass coverslip, which 
represents an extreme rigidity not seen physiologically (69 GPa vs 10-30 GPa for 
bone) (Callister, 2000; Nemir & West, 2009; Moore et al., 2010) in order to 
compare FA phenotypes with invadopodia characteristics. Immunostaining 
revealed paxillin or vinculin localization surrounding cortactin- or actin-containing 
invadopodia in adhesion rings similar to those around podosome actin core 






adhesion proteins including α5 and active β1 integrin also localized around the 
invadopodium protrusion, while active pY416 Src localized at the cortactin puncta 
(Fig. 7C). 
In order to better understand the relationship between adhesion rings, FA, 
and invadopodia activity, we performed a correlative analysis of invadopodia-
associated ECM degradation with the number of adhesion-ringed invadopodia or 
FA. To provide a richer dataset for analysis and because we previously found 
that cells modulate invadopodia activity according to substrate rigidity, we chose 
3 rigidity conditions for the analysis and cultured CA1d or SCC61 cells on FITC-
FN/1% gelatin overlaying polyacrylamide (PA) or glass invadopodia substrates of 
defined rigidity (Soft PA=1 kPa, Hard PA=10 kPa, glass=1 GPa) as previously 
described (Alexander et al., 2008; Parekh et al., 2011). After 18 h, the cultures 
were fixed and immunostained for cortactin and paxillin.  Cortactin-positive 
invadopodia puncta have a characteristic morphology and size ≥1 µm (Clark et 
al., 2007a), and were analyzed for association with ECM degradation and 
number per cell. FA number and size were analyzed from paxillin-positive 
structures at the periphery of the cell, and invadopodia-associated adhesion rings 
were identified manually.  Overall, analysis across all conditions revealed that a 
higher percentage of adhesion-ringed invadopodia puncta were associated with 
degraded ECM than were non-ringed invadopodia (Fig. 8A), suggesting that 
adhesion rings may promote invadopodia-associated degradation. We also 
correlated the number of FA and invadopodia ring structures per cell with the 
amount of degradation per cell. Interestingly, the number of paxillin-ringed 
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invadopodia peaked on the same rigidity that elicited the highest invadopodia 
activity per cell, on the hard PA gel for the CA1d cells and on the glass surface 
for the SCC61 cells (Fig. 8B-C). Using a Spearman’s rank correlation to test the 
statistical dependence between two variables, we found that the number of 
adhesion-ringed invadopodia per cell significantly and positively correlated with 
ECM degradation area/cell on a cell-by-cell basis (Fig. 8D). The number of non-
adhesion-ringed invadopodia also significantly correlated with ECM 
degradation/cell but to a lesser extent than adhesion-ringed invadopodia.  By 
contrast, except for SCC61 cells plated on glass substrates, neither the number 
nor size of FA correlated with the degradation area/cell on a cell-by-cell basis 
(Fig. 8D, 9). Altogether, these correlative data indicate that adhesion ringed-
invadopodia are highly associated with ECM degradation. 
Adhesion Rings form Shortly After Invadopodia Formation 
Because SCC61 cells on the glass surface formed the most adhesion 
ringed-invadopodia and degraded the most ECM, this condition was used to test 
the roles of adhesion rings in invadopodia function. Invadopodia have been 
shown to develop in a step-wise process, with cortactin and actin accumulation 
rapidly followed by MT1-MMP arrival and degradation of the underlying ECM 
(Artym et al., 2006). In VSMCs, rings surrounding podosomes form shortly after 
punctate localization of an actin marker (Kaverina et al., 2003). However, the 
dynamics of adhesion formation at invadopodia is not clear. The adhesion 
proteins could assemble prior to the actin accumulation to promote invadopodia 









the matrix and/or facilitate the delivery of MMPs. To this end, SCC61 cells 
expressing Tom-Tract to mark actin as well as GFP-Paxillin were cultured on 1% 
gelatin/unlabeled FN on glass coverslips and serum starved overnight. Directly 
before imaging, complete invadopodia media was added to stimulate 
invadopodia formation. The basal surface of the cells was then imaged with 
confocal microscopy with images acquired every 15 seconds for 1 hour (Fig. 
10A). In general, adhesion rings formed quickly after appearance of the actin 
puncta with a mean of 2.6 minutes and median of 2 minutes after formation of the 
invadopodium (Fig. 10B). In addition, ~90% of invadopodia formed in the 1 hour 
movies developed an adhesion ring (Fig. 10C). As previously observed (Bravo-
Cordero et al., 2011), I also recorded oscillations of the actin signal at 
invadopodia. The GFP-Paxillin ring also oscillated in intensity similarly to the 
actin, although its recovery was slightly delayed compared to the reappearance 
of the actin puncta (Fig. 10D). Occasionally, adhesion rings did not recover with 
the actin or did not appear at all during the hour of time-lapse imaging, which 
may explain the lower percentage of adhesion ringed invadopodia observed in 
fixed cell analyses (Fig. 10E). These data indicate that adhesion rings form after 
invadopodia formation. 
 
Integrin-ECM Interactions are Critical for Adhesion Ring Formation and 
Invadopodial ECM Degradation 
To test the role of integrins in invadopodia formation, adhesion ring formation, 
and invadopodia activity, SCC61 cells were incubated with an RGD peptide 
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(gRGDsp) which blocks the RGD-binding integrins from binding their ligands 
(Hayman et al., 1985), or with a combination of β1- and αvβ3 integrin blocking 
antibodies (AIIB2 + LM609) (Cheresh, 1987; Hall et al., 1990). These integrin 
targets were chosen based on the ECM substrate in the invadopodia assay (FN) 
and their described roles in invadosome or podosome activity (Nakamura et al., 
2007; Destaing et al., 2010). The cells were incubated on FITC-FN to quantify 
matrix degradation and immunostained with cortactin to mark invadopodia and 
paxillin to mark adhesion structures (Fig. 11A). Compared with gRGEsp or IgG 
antibody controls, inhibition of RGD-binding or β1 and αVβ3 integrins attachment 
to FN reduced the median area of ECM degradation/cell from 4 to 1.4 µm2 and 
6.4 to 3.1 µm2, respectively (Fig. 11B, D). The latter effect was specific to β1 
integrin blocking, as αVβ3 inhibitory antibody treatment did not significantly affect 
ECM degradation by the cells (Fig. 11F-G). The immunostaining for cortactin and 
paxillin was utilized to quantify the number of cortactin-positive invadopodia 
puncta (“Total”), the number of invadopodia surrounded by paxillin-containing 
adhesion rings (“Ringed”), and whether or not cortactin puncta had associated 
ECM degradation (“Active” or “Inactive”). Although it is possible that some of the 
“Inactive” invadopodia may represent other cortactin-positive structures, the size 
criteria of ≥1 µm diameter minimizes this possibility and use of this metric allows 
analysis of invadopodia maturation.  Furthermore, we complement such analyses 
with live cell imaging (next paragraph). Integrin inhibition with gRGDsp or 
combined AIIB2 and LM609 treatment resulted in a significant reduction in the 






effect on total invadopodia numbers (Fig. 11C, E). Furthermore, RGD-binding 
integrin inhibition with these reagents resulted in a significant decrease in the 
number of active invadopodia from a median of 3 to 1 per cell, while increasing or 
not affecting the inactive invadopodia per cell (Fig. 11C, E). Overall, these data 
indicate that integrins significantly contribute to adhesion ring formation and 
invadopodia-associated ECM degradation. 
 To directly determine if inhibition of integrins leads to a loss of proteinase 
recruitment or conversely to alterations in invadopodia dynamics, I performed live 
cell imaging. To specifically detect extracellular MT1-MMP, SCC61 cells were 
engineered to stably express low levels of the critical invadopodia protease MT1-
MMP tagged with superecliptic-pHLuorin-GFP (MT1-pHLuor). The pHLuorin tag 
exhibits greatly enhanced fluorescence at the extracellular pH of 7.4 compared to 
the more acidic intracellular vesicles (Miesenbock et al., 1998; Lizarraga et al., 
2009). After transient transfection with Tom-Tractin to visualize invadopodia, dual 
color widefield images were captured on a Deltavision microscope every 15 
seconds and computationally deconvolved to remove out of focus light. From 
these movies, times of invadopodia formation and disassembly were determined 
as the IC50 points of the background-subtracted Tom-Tractin fluorescence 
intensity fit to a sigmoid curve at the initiation or disappearance of the 
invadopodia. Invadopodia lifetime was calculated as the time between formation 
and disassembly (Fig. 12C). Invadopodia formation rate was manually calculated 
as the number of invadopodia/cell/hour (Fig 12A). MT1-MMP recruitment to 









fluorescence intensity of MT1-pHLuor at each time point subtracted from the 
initial fluorescence intensity at the time of invadopodia formation (Fig. 12D). 
Using this approach, we found that inhibition of RGD-binding integrins with 
gRGDsp had no significant effect on the rate of invadopodia formation or on 
invadopodia lifetime compared to treatment with control gRGEsp peptide (Fig. 
12A, C).  However, there was a significant reduction in the accumulation of MT1-
MMP at invadopodia (Fig. 12B, D). Thus, in control gRGEsp-treated cells, the 
MT1-MMP signal at Tom-Tractin-positive invadopodia increased steadily over the 
lifetime of individual invadopodia (Fig. 12B, D). By contrast, in gRGDsp-treated 
cells, the overall MT1-MMP accumulation rate was significantly decreased, 
suggesting that the major effect of integrin inhibition was on invadopodia 
maturation (Fig. 12B, D). 
 
Integrin-Linked Kinase Controls Adhesion Ring Formation, Invadopodia 
Dynamics and Activity 
Our live and fixed imaging results with RGD blocking peptide indicated 
that integrins are involved in both adhesion ring formation and the accumulation 
of MT1-MMP at invadopodia. Since the majority of invadopodial MT1-MMP is 
derived from exocytosis of late endocytic/lysosomal vesicles (Steffen et al., 2008; 
Hoshino et al., 2012), we hypothesized that downstream signals from integrin-
ECM attachement might regulate this process. Although little is known about the 
relationship between integrins and exocytosis (Balasubramanian et al., 2010; 
Gupton & Gertler, 2010; Wickstrom & Fassler, 2011), a possible downstream 
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candidate is integrin-linked kinase (ILK), based on its reported function 
connecting caveolar vesicles to IQGAP at adhesions (Wickstrom et al., 2010). 
Since cholesterol-rich caveolin-positive membranes and IQGAP have been 
separately shown to mediate proteinase trafficking to invadopodia (Sakurai-
Yageta et al., 2008; Caldieri et al., 2009; Yamaguchi et al., 2009), ILK is likely an 
important link between integrins and MT1-MMP-containing vesicles to promote 
the degradative activity of invadopodia. To test this hypothesis, I knocked down 
ILK in SCC61 cells. Using two separate shRNA constructs, ILK protein 
expression was decreased by 58% and 82% in ILK-KD1 and -KD2 cells 
compared with a non-targeting control (Fig. 13B). When assessed by fixed cell 
IF, ILK-KD cells exhibited a significant reduction in invadopodia-associated 
degradation, and the number of total, ringed, and active invadopodia per cell 
(Figs.13A, C-D). Consistent with the hypothesized role in invadopodia 
maturation, there was no significant difference between control and ILK-KD cells 
in the number of inactive invadopodia/cell. Combining gRGDsp treatment with 
ILK-KD had no further effect on invadopodia-associated ECM degradation 
compared with RGD treatment alone, suggesting that RGD-binding integrins 
likely function upstream of ILK (Fig. 13E). 
We also performed live cell imaging in MT1-pHLuor, Tom-Tractin-expressing 
control and ILK-KD cells to analyze the effect of ILK-KD on MT1-MMP 
accumulation and invadopodia dynamics. Unlike the effect of RGD peptide (Fig. 
12), ILK-KD led to a decrease in invadopodia formation, from a median of 28 to 
12 invadopodia per cell per hour and invadopodia lifetime from a median of 35 to 
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21 minutes. (Fig. 14A, C).  Similar to the effect of integrin inhibition with gRGDsp 
peptide, KD of ILK1 led to a large reduction in the rate of MT1-MMP recruitment 
to invadopodia (Fig. 14B). We note that unlike with RGD-inhibited cells, the 
decrease in extracellular MT1-MMP accumulation only occurred after the first 20 
min (Fig. 14D). However, overall these data indicate that integrin and ILK-
mediated adhesion signaling is critical for accumulation of extracellular MT1-
MMP at invadopodia. Since the accumulation was quantitated at already-formed 
invadopodia, the decreases in protease accumulation for both integrin- and ILK-
inhibited cells were independent of any effects on invadopodia formation or 
lifetime. 
 
Integrins and ILK Recruit IQGAP to Invadopodia 
Based on our findings that integrins and ILK affect invadopodia activity 
and MT1-MMP recruitment and the known role of the ILK-binding partner IQGAP 
in capturing caveolar vesicles (Sakurai-Yageta et al., 2008; Wickstrom et al., 
2010), I tested if blocking RGD-binding integrins or knocking down ILK affected 
IQGAP localization to invadopodia. Confocal sections show IQGAP localization 
with actin at the invadopodium, similar to previous reports (Sakurai-Yageta et al., 
2008), and with paxillin surrounding it (Fig. 15A). Confocal Z-sections 
demonstrate IQGAP localization skewed towards the top of the invadopodium 
(Fig. 15B). To determine if IQGAP is recruited to invadopodia based on integrins 
or ILK, RGD-treated or ILK-KD SCC61 cells were cultured overnight on FITC- 









IQGAP (Fig. 15C). The fluorescent intensities of actin and IQGAP at invadopodia 
were quantified from images acquired under identical laser and camera 
conditions. The ratio of IQGAP to actin intensity was then plotted. Consistent with 
a model whereby integrins and ILK facilitate IQGAP recruitment to invadopodia, 
inhibition of RGD-binding integrins or ILK-KD led to a decrease in the IQGAP to 
actin intensity ratio at invadopodia (Fig. 15 C-E). The median ratio of IQGAP to 
actin intensity decreased from 0.57 to 0.49 with RGD treatment and from 0.49 to 
0.34 and 0.37 with ILK shRNA #1 and #2, respectively, compared to controls 
(Fig. 15D-E). 
 
MT1-MMP Regulates ECM Degradation and Invadopodia Dynamics, but not 
Adhesion Ring Formation 
 Recruitment of MT1-MMP and other proteinases is thought to be a late 
stage in invadopodia formation; however several studies have reported reduced 
numbers of invadopodia/cell in proteinase-inhibited cells (Artym et al., 2006; 
Clark et al., 2007a; Steffen et al., 2008), suggesting feedback from proteolytic 
activity. To test whether MT1-MMP acts upstream or downstream of adhesion 
ring formation, SCC61 cells were transduced with shRNA targeting MT1-MMP 
and analyzed for invadopodia and adhesion ring formation and ECM degrading 
ability in fixed cell assays (Fig. 16A-B). Consistent with previous reports (Artym et 
al., 2006; Steffen et al., 2008) ECM degradation per cell was almost completely 
abolished in MT1-MMP knockdown cells (Fig. 16B-C). Furthermore, there was a 
4-fold decrease in the number of active invadopodia per cell and a corresponding 









significant change in either the number of adhesion-ringed invadopodia or the 
number of total invadopodia. Live cell imaging further revealed that the rate of 
invadopodia formation was reduced in MT1-MMP-KD cells (Fig. 16E). There was 
also a small but significant decrease in the median lifetime of invadopodia in 
MT1-MMP-KD cells from 45.5 to 35.5 minutes (Fig. 16F), suggesting that there is 
indeed a positive feedback loop that results from MT1-MMP activity at 
invadopodia (Artym et al., 2006; Clark et al., 2007a; Steffen et al., 2008). These 
data are consistent with a model in which adhesion rings form upstream of MT1-
MMP accumulation to promote ECM degradation. MT1-MMP activity itself also 




In this chapter, we examined the role of cell-ECM adhesion and 
downstream signaling in the regulation of invadopodia formation and activity.  We 
find that podosome-like adhesion rings surround invadopodia shortly after their 
formation and their presence is highly correlated with invadopodia activity.  
Integrins and ILK are critical for adhesion ring formation, localization of the 
vesicular adaptor protein IQGAP and the transmembrane proteinase MT1-MMP 
to invadopodia, and ECM degradation. Overall these data indicate that adhesion 
is critical for invadopodia maturation. 
 







Invadopodia and podosomes are both actin-rich structures that can 
degrade underlying matrix. Despite many similarities, including common 
molecular constituents and pathways of activation, invadopodia are often 
classified as distinct structures that form in cancer cells and have separate 
properties from podosomes such as longer lifetimes, protrusive behavior, and 
morphological classifications (Gimona et al., 2008; Murphy & Courtneidge, 2011). 
A major distinction is the presence of adhesion proteins surrounding the actin-
based protrusion (Gimona et al., 2008; Linder et al., 2011; Murphy & 
Courtneidge, 2011). Here, we demonstrate that two different cancer cell lines 
exhibit adhesion ring formation around the invadopodial protrusion. These rings 
consist of multiple components of classic adhesions including paxillin, vinculin, 
and β1 integrin and localize at the basal surface of the cell by confocal 
microscopy, suggesting that these are legitimate adhesive structures. However, 
they were less prominent than adhesion rings normally observed around 
podosomes, possibly due to competition with FAs for adhesion components 
(Chan et al., 2009) or a greater cytoplasmic pool of adhesion proteins in cancer 
cells that obscures observation of the ring structures. Interestingly, in 
invadosome-producing Src-transformed fibroblasts, β1 integrin was shown to be 
important not only for the organization but also for the formation of invadosome 
structures (Destaing et al., 2010). Although an effect on invadopodia formation is 
observed here with ILK KD in SCC61 cells, the primary role for RGD-binding 
integrins and ILK appears to be promotion of invadopodia maturation. Similarly, 
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in osteoclasts, despite a small effect on actin podosome puncta diameter, 
knockout of combinations of integrins β1, β2, and αv or kindlin-3 led to severe 
defects in podosome organization and bone resorption (Schmidt et al., 2011). In 
addition, Badowski et al. examined the role of paxillin in invadosome formation by 
Src-transformed cells and podosome formation by osteoclasts.  In those 
systems, loss or mutation of paxillin primarily affected podosome organization 
and ECM degradation (Badowski et al., 2008). Our data suggest that adhesion 
rings are indeed a common component of both invadopodia and podosomes and 
indicate that a major function of those rings is to promote protease recruitment 
and invadopodia maturation.  
 
A New Model of Invadopodia Stages 
Altogether, our data are consistent with a model in which adhesion rings 
are assembled shortly after invadopodia actin puncta assembly and promote 
recruitment of proteinases to allow ECM degradation (Fig. 17).  RGD-binding 
integrins and ILK are crucial components of this process as inhibition or knock-
down reduces adhesion ring formation, MT1-MMP recruitment to invadopodia 
and ECM degradation.  Furthermore, inhibiting integrins in ILK-KD cells had no 
further effect on ECM degradation, suggesting that integrins and ILK reside in the 
same pathway with respect to invadopodia-associated ECM degradation. We 
place MT1-MMP at a later stage than adhesion formation since knockdown of 
MT1-MMP had no effect on the number of adhesion-ringed invadopodia but 
inhibition of cell-ECM adhesion led to decreased recruitment of MT1-MMP.  After 
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exocytosis, MT1-MMP and other proteases might also interact with integrins via a 
direct docking mechanism (Mueller et al., 1999; Galvez et al., 2002) that could 
provide additional positive feedback to enhance invadopodia lifetime and/or ECM 
degradation. 
Whereas integrin inhibition with gRGDsp did not affect invadopodia formation or 
lifetime, ILK-KD did, indicating that ILK may not function solely downstream of 
integrins for those activities. Although ILK is thought to primarily function as a 
downstream effector of integrins in complex with PINCH and parvin (Sakai et al., 
2003; Stanchi et al., 2009; Wickstrom et al., 2010), ILK can also be regulated by 
growth factor signaling (Ho & Dagnino, 2012; Serrano et al., 2012) and PI3K (Wu 
& Dedhar, 2001). Since invadopodia formation can be activated by both growth 
factor and PI3K signaling (Yamaguchi et al., 2005; Yamaguchi et al., 2011), one 
possibility is that the regulation of invadopodia dynamics by ILK may occur 
downstream of growth factors rather than integrins.  Another possibility is that the 
inhibition of RGD-binding integrins with gRGDsp was less effective at blocking 
the integrin-ILK-IQGAP-MT1-MMP pathway than ILK-KD.  Since knockdown of 
MT1-MMP itself can affect invadopodia dynamics (Fig. 16), a more complete 
block of the pathway with ILK-KD might lead to the difference that we noted for 
invadopodia dynamics. 
 
Regulation of Exocytosis by Integrins and ILK 
Integrins and adhesion signaling have recently been shown to affect 







were shown to be regulated by integrin adhesion and paxillin through activation 
of the RalA GTPase (Spiczka & Yeaman, 2008; Balasubramanian et al., 2010). 
β1 Integrin-ECM interaction was also recently shown to promote exocytosis of 
lipid rafts by a mechanism that links ILK, the scaffold protein IQGAP1 and the 
formin mDia1 to capture of microtubules and subsequent vesicle delivery to the 
plasma membrane (Wickstrom et al., 2010; Wickstrom & Fassler, 2011). 
Furthermore, integrin adhesion to collagen in 3D was shown to promote 
polarized trafficking of MT1-MMP (Bravo-Cordero et al., 2007). Of note, several 
microtubule motors have been shown to regulate exocytosis of MT1-MMP at 
podosomes (Wiesner et al., 2010; Cornfine et al., 2011). Furthermore, the 
exocyst complex localizes to invadopodia through IQGAP1 and is important for 
MT1-MMP localization to invadopodia (Sakurai-Yageta et al., 2008). In light of 
these data and our finding that IQGAP localization to invadopodia is reduced in 
integrin- and ILK-KD cells (Fig. 15), we speculate that adhesion rings 
surrounding invadopodia may promote targeted MT1-MMP recruitment to 
invadopodia through capture of vesicles via a similar ILK-IQGAP-mediated 
mechanism (Fig. 17). 
Deregulation of β1 integrin and ILK signaling has been implicated in a 
wide range of aggressive tumor behaviors, including cancer invasion (Dai et al., 
2003; Guo & Giancotti, 2004; Sawai et al., 2006; Lu et al., 2008; Poincloux et al., 
2009). With regard to ECM degradation and cancer invasion, our data suggest 
that at least one key mechanism may be via integrin-ILK-mediated regulation of 
protease secretion at invadopodia. Interestingly, ILK-regulated secretion has also 
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been implicated in tumor angiogenesis and caveolar formation (Edwards et al., 
2008; Wickstrom et al., 2010). Future studies should address how general the 
secretory defect is from integrin-ILK signaling and to what extent invadopodia 





DISCUSSION AND FUTURE DIRECTIONS 
 
Mechanosensing at Invadopodia 
 As a whole, my data support the concept that integrin-mediated 
mechanotransduction promotes the functionality of invadopodia via recruitment of 
MT1-MMP. In Alexander et al., we demonstrated that general substrate rigidity 
specifically promotes invadopodia activity. This response is enhanced by the 
overexpression of the mechanosensing proteins FAK and p130Cas. We also 
observed localization of FAK and p130Cas to the invadopodia core and of 
myosin IIA, active β1 integrin, paxillin, and vinculin to invadopodia rings. As a 
result, invadopodia appear to be bona fide adhesive structures and 
mechanosensing organelles. Invadosome/podosome rosettes in fibroblasts and 
macrophages have in fact been shown to exert force on the substrate similar to 
FAs (Collin et al., 2006; Collin et al., 2008; Labernadie et al., 2010). This effect 
has not been demonstrated for invadopodia and might be difficult to assess due 
to their small size compared to podosome rosettes and FAs. It is interesting to 
speculate, however, that subcellular force changes mediated by ECM topography 
or compositional heterogeneity in vivo could locally induce ECM degradation. 
Alternatively, forces induced on a subcellular scale can lead to long distance 
signaling responses (Wang et al., 2005) which could also mediate rigidity 
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responses. Overall, these data indicate a strong relationship between ECM 
rigidity and tissue degradation, which is likely to be enhanced in tumors that are 
exposed to a more rigid environment than normal epithelial cells experience 
(Paszek et al., 2005). 
 
Integrin-ECM Regulation of Invadopodia Activity 
Integrin heterodimers exert differential effects on cellular phenotypes that 
are triggered by interactions with specific ECM ligands (Danen et al., 2002; Orr et 
al., 2006; Roca-Cusachs et al., 2009). Interestingly, treatment of cells with a β1 
integrin blocking antibody can lead to differential effects on invadopodia activity 
depending on the cellular and ECM context (Liu et al., 2009b; Branch et al., 
2012). In Liu et al., treatment of bladder carcinoma cells with a β1 integrin 
blocking antibody mimicked the effect of laminin-332 knockdown, as attachment 
to laminin-332 reduced invadopodia numbers (Liu et al., 2009b). By contrast, in 
cells plated on FN, we found that treatment with either an RGD blocking peptide 
or an antibody that blocks β1 integrin-ligand interactions inhibits invadopodia 
maturation. Therefore, specific ECM-integrin interactions may lead to divergent 
effects on invadopodia activity. 
  
Cooperation between Mechanical Signals and Growth Factor Signaling in 
Invadopodia Progression 
Our data show that integrin-ECM attachment and ILK promote maturation 
of invadopodia, as defined by protease exocytosis. Integrin-mediated 
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mechanotransduction also results in a specific increase in functional, but not 
total, invadopodia numbers. Invadopodia formation instead appears to depend on 
growth factor signaling and can be induced by a number of growth factors 
including EGF, VEGF, and TGF-β (Yamaguchi et al., 2005; Mandal et al., 2008; 
Lucas et al., 2010). In many of these situations, growth factor-induced 
invadopodia formation requires PI3K, possibly leading to formation of PI(3,4)P2 
and recruitment of initiators of invadopodia such as Tks5 (Seals et al., 2005; 
Yamaguchi et al., 2011; Hoshino et al., in revision). These data lead to a model 
in which growth factor signaling and integrin-mediated mechanotransduction 




Mechanism of Protease Recruitment to Invadopodia by Integrins 
Integrins promote cell surface protease expression through a variety of 
mechanisms, including alterations in protein expression, direct docking of 
vesicles, or activation of signaling pathways to promote trafficking (Deryugina et 
al., 2001; Ellerbroek et al., 2001; Galvez et al., 2002; Matias-Roman et al., 2005; 
Tomari et al., 2009; Yamaguchi et al., 2009; Balasubramanian et al., 2010). 
However, the exact mechanism for the observed decrease in MT1-MMP at 
invadopodia in response to ILK KD or RGD peptide block of integrin adhesion 
remains undetermined. We did find that blocking integrins or ILK led to a 
decrease in the intensity of IQGAP staining at invadopodia.  We therefore favor a 
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model in which an integrin-ILK-IQGAP complex recruits lipid raft-rich vesicles 
(Wickstrom et al., 2010) containing proteases to invadopodia by promoting 
docking via the exocyst complex (Sakurai-Yageta et al., 2008).  However, that 
model has not yet been formally tested.  Therefore, an important future direction 
is to directly quantitate MT1-MMP-containing vesicle docking by TIRF 
microscopy or other methods.  We could also measure the trafficking of lipid raft-
containing vesicles to invadopodia in response to integrin, ILK, or IQGAP 
inhibition to assess a possible defect in general secretion to invadopodia with 
blocking or knockdown of these proteins. 
 
Feedback from Adhesions to Invadopodia Formation 
 Growth factor – PI3K signaling is emerging as a critical initiating factor for 
invadopodia protrusion (Yamaguchi et al., 2011; Hoshino et al., in revision), while 
our data point to integrins as mediating protease recruitment for invadopodia 
maturation (Branch et al., 2012). However, additional data suggests a positive 
feedback emanating from proteolytic activity at invadopodia.  Thus, knockdown 
or inhibition of invadopodial proteases, or of proteins required for protease 
recruitment to invadopodia, not only greatly inhibits matrix degradation but also 
reduces invadopodia number (Artym et al., 2006; Clark et al., 2007a; Steffen et 
al., 2008). Consistent with those studies and with a positive feedback model, in 
our live imaging studies, we found that knockdown of MT1-MMP led to both a 
reduced rate of invadopodia formation, as well as a decreased lifetime of 
individual invadopodial structures (Branch et al., 2012). The feedback could 
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occur via the release of growth factors or ECM fragments from the ECM. 
Alternatively, proteases can cleave and alter the activity of growth factors or 
growth factor receptors themselves (Lehti et al., 2005; Kessenbrock et al., 2010; 
Koshikawa et al., 2010). Future studies should determine the roles of proteolytic 
growth factor release and activation in invadopodia formation. 
An increase in integrin activity could also crosstalk with growth factor 
receptor signaling to provide additional feedback and promote invadopodia 
formation. We did observe a decrease in the formation of invadopodia with ILK 
knockdown, although ILK is also implicated in cellular processes downstream of 
growth factors such as EGF (Esfandiarei et al., 2010; Ho & Dagnino, 2012). 
Interestingly, EGF-induced Src activation is amplified by cell attachment to FN 
and this process requires ILK (Azimifar et al., 2012). Also, EGF-induced PI3K-Akt 
signaling is amplified by auto-clustered β1 integrin or increased ECM stiffness 
(Levental et al., 2009). Since specific integrin-ECM interactions have apparent 
varying effects on invadopodia formation and function (Liu et al., 2009b; Branch 
et al., 2012), one possibility is that divergent downstream signaling interfaces 
differentially with growth factor signaling pathways. An important future direction 
is therefore to determine which integrin-ECM interactions promote maximal 
invadopodia activity as well as to identify synergy of these pathways with growth 
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